The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

NCT05279248 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Human Papilloma Virus Infection Type 16
Human Papilloma Virus Infection Type 18
Measles
Rubella
Mumps

Interventions

BIOLOGICAL: HPV+MMR（0d），HPV（6m）
BIOLOGICAL: HPV（0d），HPV（6m），MMR（7m）
BIOLOGICAL: MMR（0d），HPV（1m），HPV（7m）

Sponsor

Zhejiang Provincial Center for Disease Control and Prevention